Hypertrophic Cardiomyopathy Treatment in Israel
HCM, or hypertrophic cardiomyopathy, refers to an enlargement of a portion of the heart muscle, which leads to functional impairment. It is one of the leading causes of sudden cardiac death. While it can lead to shortness of breath, angina, palpitations and syncope, it is often asymptomatic until sudden cardiac death. That is why heart specialists recommend regular screenings for people at risk of developing the condition.
Sample Treatment Program
Diagnostics:
- Stress echocardiography
- Cardiologist consultation
Treatment:
If surgical intervention is required you will be referred for a septal myectomy, an open-heart surgery that is considered low-risk, and takes approximately 3-5 hours. It will be preceded by routine preoperative investigations (bloodwork, chest X-ray, anesthesiologist consultation).
Cost of treatment will normally include the surgery itself, post-operative monitoring and up to 7 days of hospitalization.
Toronto: 
London: 
